Bilbiografia:
1. Novalbos J, Santos FA. La arginina mejora la eficacia y seguridad del ibuprofeno. Actualidad en Farmacología y Terapéutica. 2006;4(1 ):23-34. 2. Ceppi Monti N et al. Activity and Pharmacokinetics of a New Oral Dosage form of soluble Ibuprofen. Arzneimforschung 1992; 42(4): 556-559. 3. Cattaneo D, Clementi E. Clinical pharmacokinetics of ibuprofen arginine. Current Clinical Pharmacology. 2010;5(4):239-45. 4. Gallego-Sandin S, Novalbos J, Rosado A, et al. Effect of ibuprofen on cyclooxygenase and nitric oxide synthase of gastric mucosa: correlation with endoscopic lesions and adverse reactions. Digestive Diseases & Sciences. 2004;49(9): 1538-44. 5. Calero MJ, Jiménez MD, Lastra C, et al. Protective Effect of L-Arginine Against lbuprofen-induced Gastric lnjury in Rats. Pharmacy and Pharmacology Communications. 1997;3(12):609-12. 6. Jiménez D, Martín MJ, Pozo D, et al. Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins. Digestive Diseases & Sciences. 2002;47(1):44-53. 7. De Miguel C, García C, Mella M, et al. Comparative Efficacy of Oral lbuprofen-Arginine, Intramuscular Magnesic Dipyrone and Placebo in Patients with Postoperative Pain Following Total Hip Replacement. Clinical Drug lnvestigation. 1997; 14(4):276-85.